Document is current
Any future updates will be listed below
-
Authors
Joglekar, Mugdha V. https://orcid.org/0000-0001-5346-2266
Wong, Wilson K. M.
Kunte, Pooja S.
Hardikar, Hrishikesh P.
Kulkarni, Reshmi A. https://orcid.org/0009-0000-9156-0617
Ahmed, Ikhlak https://orcid.org/0000-0002-5753-9627
Farr, Ryan J. https://orcid.org/0000-0003-1636-1815
Pham, Nhan Ho Trong
Coles, Madilyn
Kaur, Simranjeet https://orcid.org/0000-0003-0490-1028
Maynard, Cody L.
Hayward, Riley
Thorat, Vinod
Pant, Aniruddha
Akil, Ammira A.
Donaghue, Kim C.
Jenkins, Alicia J.
Piya, Milan K.
Craig, Maria E. https://orcid.org/0000-0001-6004-576X
Hague, William M.
Yajnik, Chittaranjan S. https://orcid.org/0000-0002-2911-2378
Chan, Juliana C. N. https://orcid.org/0000-0003-1325-1194
Shapiro, A. M. James
Davis, Elizabeth A.
Jones, Timothy W.
Gitelman, Stephen E.
Ma, Ronald C. W. https://orcid.org/0000-0002-1227-803X
Pociot, Flemming
Hardikar, Anandwardhan A. https://orcid.org/0000-0001-5587-2090
,
Taylor, Caroline J.
Pereira E Cotta, Maria Virginia
Sachithanandan, Nirupa
Dong, Charlotte X.
Ema, Fahmida K.
Perera, Sathya
Satoor, Sarang N.
Bapat, Sharda
Cho, Yoon Hi
Januszewski, Andrzej S.
Scott, Emma S.
Acosta Reyes, Pamela
Chimoriya, Ritesh
Isaacs, Sonia R.
Coat, Suzette
Bhat, Dattatray
Bhalerao, Aboli
Baptist, Alma
Wagh, Rucha
Dhadge, Smita
Gokhale, Vidya
Jog, Kalpana
Limaye, Tejas
Thuse, Neelima
Jiang, Guozhi
Purwana, Indri
Qureshi, Saira
Senior, Peter A.
Paramalingam, Nirubasini
Saxon, Chontiey
Guillemin, Gilles J.
Loudovaris, Thomas
Thomas, Helen E.
Martin, David
Gamble, Jennifer R.
O’Neal, David N.
Lappas, Martha
Shultz, Sandy R.
McDonald, Stuart J.
Hosseini-Beheshti, Elham
Grau, Georges E.
Hawthorne, Wayne J.
Limaye, Amita
Bright, Ralph
Patil, Rohan R.
Karandikar, Mahesh S.
Joglekar, Sheela V.
Joglekar, Vinay M.
Rowan, Janet A.
Lim, Noha
- License Information
-
More Information
Article History
Received: 8 September 2024
Accepted: 16 April 2025
First Online: 5 June 2025
Competing interests
: S.E.G. has served on advisory boards for Abata, Genentech, GentiBio, Provention Bio, SAB Biotherapeutics, Sanofi and Shoreline Biosciences. He has received support from Provention Bio, Sanofi and the National Institutes of Health for his roles in conducting clinical trials. He serves on data and safety monitoring boards for Diamyd Medical, Breakthrough T1D and INNODIA. F.P. has received advisory and lecture fees from Sanofi Aventis. A.A.H. has served on the advisory boards of Abbott and Mylan, and has received grants through Breakthrough T1D and the Novo Nordisk Foundation to identify the biomarkers and regulators of diabetes progression. He has been funded through The Leona M. and Harry B. Helmsley Charitable Trust to develop a nanotechnology-based method for miRNA detection. The other authors declare no competing interests.
